Preview the next wave of bioscience start-ups in this fast-paced program comprised of ten emerging, seed and early-stage companies. Qualified ventures will include those evolving out of technology transfer offices or companies taking their first steps along the commercialization pathway, conducting proof-of-concept research, developing a prototype, or otherwise executing their business and product development plans. Listen to the start-ups make their pitches, hear the critiques by distinguished judges, and learn about exciting new technologies and products.
Ken Massey, PhD, Senior Director, Venture Development, Wayne State University
Tom Shehab, MD, Principal, Arboretum Ventures
David Strickler, Vice President, Cascade Partners
Participants will be presenting during one of three time slots, with an award presentation taking place on the final day of the conference.
View the complete agenda for details.
2:00 pm -- Michigan State University: Novel DNA Deep Sequencing Technologies (company abstract)
2:20 pm -- Sisu Global Health
2:40 pm -- Deuwave, LLC (company abstract)
October 1st; 8:30 - 9:30 am
8:30 am -- Functional Fluidics, LLC (company abstract)
8:50 am -- Exo Dynamics (company abstract)
9:10 am -- ONL Therapeutics, Inc. (company abstract)
October 1st; 1:00 - 2:00 pm
1:00 pm -- Advanced Interactive Response Systems (AIRS) (company abstract)
1:20 pm -- Fluition, LLC (company abstract)
1:40 pm -- Havanomics (company abstract)
Questions can be directed to Dave McGuire, firstname.lastname@example.org.